KYUNGYON-EXHIBITION
14.3.2022 08:02:04 CET | Business Wire | Press release
KOREA PACK and ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week), the largest packaging, cosmetic and pharmaceutical exhibition in Korea, will be held at KINTEX from June 14th to 17th as hybrid events hosted by Kyungyon Exhibition Corp.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220314005042/en/
KOREA PACK 2022 will cover such main product groups as Packaging Machinery, Packaging Materials & Containers, Package Printing Machines, Packaging Inspection Equipment, Packaging Processing Machinery & Equipment, Package Design, Services, Food Processing Machinery and Logistics System & Equipment. KOREA PACK is distinguished by its unique breadth of products and services and the unparalleled internationality of its exhibitors and visitors alike.
ICPI WEEK, International Cosmetic & Pharmaceutical Industry Week, consists of 6 concurrent events: The 12th Materials Handling & Logistics Exhibition (KOREA MAT), The 17th Cosmetic, Pharmaceutical, Bio Process & Technology Exhibition (COPHEX), Int’l Exhibition for Chemical Processing and Fine & Specialty Chemicals (KOREA CHEM), The 12th Korea Pharmaceutical and Bio-Pharma Exhibition (KOREA PHARM & BIO), The 16th Laboratory, Analytical Equipment & Biotechnology Exhibition (KOREA LAB) and The Cosmetic Ingredient & Technology Exhibition (CI KOREA). Through these events, visitors can see everything from the development, R&D, to production, packaging, logistics, and distribution of products.
With a scale of 1,500 companies and 3,500 booths, 80,000sqm (scheduled), KOREA PACK & ICPI WEEK is the biggest packaging, cosmetic and pharmaceutical B2B exhibition in Korea. For exhibitors, the deadline for registration is March 18, 2022. Now, it is possible to register as a visitor for free entry.
Launching of the Global O2O Business Platform of KOREA PACK & ICPI WEEK
A premium online platform of KOREA PACK & ICPI WEEK will be arranged for an active business exchange. In preparation for the prolonged COVID-19, the organizer will support connecting suppliers and consumers in a non-face-to-face manner for a continuous business. This platform is to showcase exhibitors’ products and technology, arrange online business meetings, and give information on the latest trends through online seminars and conferences.
In the online platform, AI will connect recommendable buyers and exhibitors so that they can find optimal partners and connect their businesses. This online platform can be joined anytime (for 365 days) as an exhibitor or a buyer.
Offline event page: https://www.koreapack.org/eng/main.asp
Online event page: online.pack-icpi.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220314005042/en/
Link:
Social Media:
https://www.facebook.com/Icpiweek-Pack-exhibition-106143351578341/?ref=pages_you_manage
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fourthline Trust Services Granted Status as Qualified Trust Service Provider in the EU24.8.2026 15:13:00 CEST | Press release
QTSP status allows for full control over the digital trust value chain from identity verification to qualified electronic signature (QES) issuance Fourthline Trust Services AB, a subsidiary of Fourthline, has been granted qualified status under the EU's eIDAS Regulation (910/2014)¹ and is now listed on the EU Trusted List as a Qualified Trust Service Provider (QTSP). Supervised by the Swedish Post and Telecom Authority (Post- och telestyrelsen, PTS), Fourthline Trust Services AB issues qualified certificates for electronic signatures. Fourthline, is the leading European provider of AI-powered identity verification (IDV) and compliance solutions. This milestone allows Fourthline full control over the entire digital trust value chain from identity verification to qualified electronic signature (QES) issuance. Ralph Post, Fourthline Trust Services AB Board Member: "By building our QTSP infrastructure similar to our sovereign AI-powered platform that drives our industry-leading identity ve
SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release
New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p
Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release
By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release
Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom